Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation (Tables)

v3.4.0.3
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2016
Schedule of stock-based compensation expense

Included in the accompanying condensed consolidated statements of operations are the following amounts of stock-based compensation for the three months ended March 31, 2016 and 2015 (amounts in thousands):

 

 

 

 

 

 

 

 

 

Three months

 

 

 

ended

 

 

 

March 31,

 

 

 

2016

 

2015

 

Operating expense

    

$

2

    

 —

 

Selling, general and administrative

 

 

1,546

 

1,331

 

Research and development

 

 

74

 

24

 

 

 

$

1,622

 

1,355

 

 

Class A common stock  
Schedule of stock awards activity

 

 

 

 

 

 

 

 

 

 

 

 

    

    

    

    

 

    

Weighted

    

    

 

 

 

 

 

 

 

 

average

 

 

 

 

 

 

 

 

 

 

remaining

 

Aggregate

 

 

 

 

 

 

 

contractual

 

intrinsic

 

 

Series A

 

WAEP

 

life

 

value

 

 

(in thousands)

 

 

 

 

(in years)

 

(in millions)

Outstanding at January 1, 2016

 

630

 

$

32.36

 

 

 

 

 

Granted

 

 

 

$

 

 

 

 

 

 

Exercised

 

(58)

 

$

31.63

 

 

 

 

 

Forfeited/Cancelled

 

 —

 

$

 —

 

 

 

 

 

Outstanding at March 31, 2016

 

572

 

$

32.43

 

2.9

 

$

15

Exercisable at March 31, 2016

 

551

 

$

32.28

 

2.8

 

$

14

 

Class C common stock  
Schedule of stock awards activity

 

 

 

 

 

 

 

 

 

 

 

 

    

    

    

    

 

    

Weighted

    

    

 

 

 

 

 

 

 

 

average

 

 

 

 

 

 

 

 

 

 

remaining

 

Aggregate

 

 

 

 

 

 

 

contractual

 

intrinsic

 

 

Series C

 

WAEP

 

life

 

value

 

 

(in thousands)

 

 

 

 

(in years)

 

(in millions)

Outstanding at January 1, 2016

 

2,761

 

$

41.09

 

 

 

 

 

Granted

 

 —

 

$

 —

 

 

 

 

 

Exercised

 

(149)

 

$

31.97

 

 

 

 

 

Forfeited/cancelled

 

 —

 

$

 —

 

 

 

 

 

Outstanding at March 31, 2016

 

2,612

 

$

41.61

 

6.3

 

$

43

Exercisable at March 31, 2016

 

1,040

 

$

32.22

 

2.8

 

$

27